Venus Remedies Limited uses cookies to improve site functionality, provide you with a better browsing experience, and to enable our partners to advertise to you. Detailed information on the use of cookies on this Site, and how you can decline them, is provided in our Privacy Policy. By using this Site or clicking on "OK", you consent to the use of cookies.
venus pharmaceutical
  • Research
    • AMR
    • Research Process
    • Pharmacovigilance
    • Visit VMRC
    • Events
  • About Us
    About Us Overview
    • Our Strategy
    • History
    • Operations
    • Board of Directors
    • Executive Team
    • Accreditation
    • Awards
    • Ethics & Compliance
    • IT Infrastructure
    • Global Presence
    • Responsibility
    • Contact Us
    FEATURED
    • Venus Remedies' Bleomycin Receives UK Market Authorization

      Venus Pharma GmbH achieves MHRA (United Kingdom) approval for Bleomycin 15,000 IU, advancing global cancer care with innovative solutions.

    • Venus Remedies' Oncology Drugs Approval in Philippines

      Venus Remedies secures marketing approval for 6 chemotherapy drugs in the Philippines, paving the way for improved cancer care in Southeast Asia

    • Elores Launch in Ecuador: Venus Remedies' Global Expansion

      Venus Remedies takes a significant stride with Elores in Ecuador, an antibiotic for antibiotic resistance, opening doors in Latin America.

  • Media
  • Career
    • Find a Job
  • Our Presence
    • IB Presence
    • Global Presence
    • Collaboration
  • Products
    • Research-Based
    • Generic
    • Digital Payment

Venus Remedies Limited

{{title.title}}

{{sidemenu1.title}}
{{title2.subtitle}}
© 2023 Venus Remedies Limited